<DOC>
	<DOCNO>NCT02340078</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety HA IDF II plus ( lidocaine ) inject nasolabial fold compare HA IDF II ( without lidocaine ) .</brief_summary>
	<brief_title>A Clinical Study Evaluate Efficacy Safety HA IDF II Plus Versus HA IDF II Nasolabial Fold Injection</brief_title>
	<detailed_description />
	<criteria>1 . Women age 30 60 2 . Those whose wrinkle treatment area ( nasolabial fold ) correspond Stage 3 4 5stage Wrinkle Severity Rating Scale ( WSRS ) symmetrically 3 . Those informed purpose , method , effect etc . study sign informed consent form 4 . Those fell follow 3 case : 1 . Surgically sterile woman 2 . Women menopause 2 year last menstruation , age least 45 3 . Among woman meet neither b , agree use least 2 contraception method specify ( one barrier method must include ) 14 day last treatment investigational device Barrier method : Condom , diaphragm , cervical cap ( pessary ) , spermicide Hormonal method : Pills , injection ( depot ) , skin patch , hormonal implant ( Implanon ) , vaginal ring Intrauterine device ( IUDs ) : Cooper IUD ( Loop ) , hormonal IUD ( Mirena ) Natural method : Basic body temperature , ovulation period , coitus interruptus , abstinent 1 . Those skin disease ( skin infection , eczema , psoriasis , rosacea , herpes etc . ) low 2/3 part face wrinkle evaluation may affect 2 . Patients malignant tumor recognize medically important consider potentially affect clinical study 3 . Women pregnancy lactation 4 . Those bilirubin level exceed 1.5 time upper limit normal ALT/AST level exceed 2.5 time upper limit normal 5 . Those confirmed infection syphilis HIV 6 . Those anticoagulant therapy antiplatelet therapy within 2 week prior Visit 1 ( screen ) 7 . Those used topical preparation ( steroid , retinoid ) facial area within 4 week prior Visit 2 ( randomization ) 8 . Those experienced deep chemical peeling procedure judge potentially affect clinical study within 3 month prior Visit 2 ( randomization ) 9 . Those experienced nonpermanent filler procedure cosmetic surgery face within 9 month prior Visit 2 ( randomization ) 10 . Those implantation procedure permanent substance ( silicone , PAAG , PMMA , CaHA etc . ) treatment area ( nasolabial fold ) 11 . Those currently streptococcal disease 12 . Those history severe allergy hypersensitivity ( anaphylaxis ) judge potentially affect clinical study 13 . Those history hypertrophic scar keloid 14 . Those history bleed disorder 15 . Those hypersensitivity investigational device clinical study lidocaine 16 . Those refuse agree use local systemic painrelieving agent painrelieving method ( e.g . : ice pack ) midnight treatment day investigational device postmeasurement last VAS pain scale 17 . Those participate another clinical study within 1 month prior Visit 1 ( screen ) 18 . Those judged investigator ineligible clinical study</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>facial nasolabial fold</keyword>
</DOC>